We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.8B
AUM Growth
+$1.26B
(+7.6%)
Cap. Flow
+$567M
Cap. Flow
% of AUM
3.2%
Top 10 Holdings %
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$82.7M |
| 2 |
PepsiCo
PEP
|
+$76.8M |
| 3 |
Marriott International
MAR
|
+$64.8M |
| 4 |
Tyson Foods
TSN
|
+$62.8M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$64.8M |
| 2 |
Hormel Foods
HRL
|
+$61.4M |
| 3 |
Gilead Sciences
GILD
|
+$59.9M |
| 4 |
Hilton Worldwide
HLT
|
+$54.7M |
| 5 |
TechnipFMC
FTI
|
+$51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.71% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Advance Auto Parts
AAP
$3.37B
| $7.38M | 0.04% |
49,502
-1,222
| -2% | -$195K |
|
|
NTT
377
DELISTED
Nippon Telegraph & Telephone
NTT
| $7.36M | 0.04% |
160,710
+1,388
| +0.9% | +$64.8K |
|
378
Coca-Cola Europacific Partners
CCEP
$46.5B
| $7.31M | 0.04% |
183,275
+5,107
| +3% | +$195K |
|
|
WES
379
DELISTED
Western Gas Partners Lp
WES
| $7.25M | 0.04% |
131,725
+13,338
| +11% | +$668K |
|
380
Unum
UNM
$13.8B
| $7.18M | 0.04% |
203,360
+121,226
| +148% | +$4.1M |
|
|
LLTC
381
DELISTED
Linear Technology Corp
LLTC
| $7.17M | 0.04% |
120,899
+2,879
| +2% | +$161K |
|
|
KYO
382
DELISTED
Kyocera Adr
KYO
| $7.13M | 0.04% |
148,277
+102,696
| +225% | +$4.94M |
|
383
Mondelez International
MDLZ
$77.7B
| $7.1M | 0.04% |
161,865
+63,697
| +65% | +$2.79M |
|
|
AZ
384
DELISTED
Allianz Se Sponsored Adr Repstg 1/10 Ord Sh
AZ
| $7.05M | 0.04% |
474,795
+6,304
| +1% | +$93.6K |
|
385
Johnson Controls International
JCI
$87.5B
| $7.02M | 0.04% |
150,971
-26,851
| -15% | -$1.24M |
|
|
NATL
386
DELISTED
National Interstate Corporation
NATL
| $7.02M | 0.04% |
215,710
| – | – |
|
|
JWN
387
DELISTED
Nordstrom
JWN
| $6.88M | 0.04% |
132,653
+11,564
| +10% | +$543K |
|
388
Hershey
HSY
$35.4B
| $6.85M | 0.04% |
71,656
+496
| +0.7% | +$52.5K |
|
389
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $6.8M | 0.04% |
219,765
+45,610
| +26% | +$1.41M |
|
|
STJ
390
DELISTED
St Jude Medical
STJ
| $6.7M | 0.04% |
83,996
-4,707
| -5% | -$380K |
|
|
DCM
391
DELISTED
NTT DOCOMO, Inc.
DCM
| $6.62M | 0.04% |
260,592
-8,335
| -3% | -$220K |
|
392
Bank of America
BAC
$435B
| $6.61M | 0.04% |
422,570
-74,533
| -15% | -$1.11M |
|
393
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.5B
| $6.52M | 0.04% |
124,453
+4,779
| +4% | +$242K |
|
394
Oneok
OKE
$58.7B
| $6.5M | 0.04% |
126,553
+35,882
| +40% | +$1.7M |
|
395
Carnival Corporation Ltd
CCL
$36.1B
| $6.48M | 0.04% |
132,739
-552,755
| -81% | -$25.6M |
|
|
RDS.A
396
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $6.47M | 0.04% |
129,342
-3,768
| -3% | -$192K |
|
397
MetLife
MET
$61B
| $6.47M | 0.04% |
163,437
+9,772
| +6% | +$367K |
|
398
Exelon
EXC
$48.6B
| $6.38M | 0.04% |
268,796
-76,476
| -22% | -$1.92M |
|
|
ETP
399
DELISTED
Energy Transfer Partners L.p.
ETP
| $6.26M | 0.04% |
169,230
-2,419
| -1% | -$95.1K |
|
400
Oxford Industries
OXM
$577M
| $6.25M | 0.04% |
+92,366
| New | +$5.78M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2016 Portfolio in Review
As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.
- Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
- Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
- Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
- Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
- Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
- Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
- Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.
Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.